Evidence map›Paper›PMID 34206235›Full record

ArticleGenes2021

Genomic Investigation of Carbapenem-Resistant

Osama Madni, Daniel G Amoako, Akebe Luther King Abia, Joan Rout, Sabiha Yusuf Essack

Open access · goldAbstract read
In one paragraph

Article in Genes, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 2 pooled it
1.2field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 2 syntheses or guidelines pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Factors associated withSouthern African journal of infectious diseases · 2026
    Article
  5. Article
  6. Virulence · 2025
    Article
  7. Article
  8. Article
  9. Antibiotic resistance and novel Sequence Types ofCurrent research in microbial sciences · 2025
    Article
  10. Review
  11. Molecular Screening of Carbapenem-ResistantJournal of clinical medicine · 2023
    Article
  12. Review
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Osama MadniAntimicrobial Research Unit, College of Health Sciences, University of KwaZulu-Natal, Durban 4000, South Africa.ORCID 0000-0001-5189-0240
Daniel G AmoakoAntimicrobial Research Unit, College of Health Sciences, University of KwaZulu-Natal, Durban 4000, South Africa.ORCID 0000-0003-3551-3458
Akebe Luther King AbiaAntimicrobial Research Unit, College of Health Sciences, University of KwaZulu-Natal, Durban 4000, South Africa.ORCID 0000-0002-5194-2810
Joan RoutSchool of Nursing, College of Health Sciences, University of KwaZulu-Natal, Durban 4000, South Africa.ORCID 0000-0002-2100-1980
Sabiha Yusuf EssackAntimicrobial Research Unit, College of Health Sciences, University of KwaZulu-Natal, Durban 4000, South Africa.ORCID 0000-0003-3357-2761
University of KwaZulu-Natal · ZA

Funding

Medical Research Council
6 · The paper itself

Abstract

The study investigated carbapenemase-producing

Indexed as

Anti-Bacterial AgentsBacterial Proteinsbeta-LactamasesDrug Resistance, Multiple, BacterialGenome, BacterialHumansIntensive Care UnitsKlebsiella InfectionsKlebsiella pneumoniaeRectumSouth AfricaWhole Genome SequencingAnti-Bacterial AgentsBacterial Proteinsbeta-Lactamasescarbapenemasecarbapenem resistanceEnterobacteralesintensive careKlebsiella pneumoniaeSouth Africawhole genome sequencing

Identifiers

PMID34206235
PMCPMC8308027
OpenAlexW3174899976

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.